about
Real-world study of everolimus in advanced progressive neuroendocrine tumors.Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.Molecular pathology and genetics of pancreatic endocrine tumours.Somatostatin receptor subtypes: basic pharmacology and tissue distribution.Unlabelled somatostatin analogues in treatment of digestive endocrine tumours.Gastric neuroendocrine tumors.Endocrine tumours of the stomach.Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problemsDigestive neuroendocrine neoplasms: A 2016 overview.Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells.Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study.Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in Europe.Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid.Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients.Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors.Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate.Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome.Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis.Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression.Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence.Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours.Large hiatal hernia in patients with iron deficiency anaemia: a prospective study on prevalence and treatment.Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy.The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors.Symptom-based approach to colorectal cancer: survey of primary care physicians in Italy.Evaluation of the Relationships Between Computed Tomography Features, Pathological Findings, and Prognostic Risk Assessment in Gastrointestinal Stromal Tumors.Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas.Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas.Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patientsKi-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective studyLong-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinomaPrognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localizationAbdominal tuberculosis with pancreatic involvement: a case reportLong-term octreotide treatment of metastatic carcinoid tumorCo-existence of hyperparathyroidism, hypergastrinaemia and multiple gastric carcinoids is not always due to incomplete expression of the MEN-1 syndromeCorpus-predominant gastritis as a risk factor for false-negative 13C-urea breath test resultsRhabdomyolysis due to severe hypokaliemia in a Crohn's disease patient after budesonide treatmentCan patient characteristics predict the outcome of endoscopic evaluation of iron deficiency anemia: a multiple logistic regression analysisClinical relevance of the expression of somatostatin receptors in digestive endocrine tumours
P50
Q33417013-285EF24A-A93D-4450-913F-70DECE7EA08DQ33828850-BA6F4543-F37E-416A-9B41-56261B11BE70Q34274982-9C8675BE-A72D-4968-9278-A26548D9FFF6Q35743371-DA2E1B63-B718-4812-BED8-6B51D36C3289Q35743388-1EEF8290-C5C1-4EA1-B47F-40DBC8030DD7Q35914982-587A9B1D-0AEB-46F2-B0FD-131EAE674E12Q36299136-4CD960C0-8B40-4DCA-BD22-5E916B9627D8Q38076275-930C1AB2-A973-4A14-9B98-546C9D1041B7Q38841440-B9DF8AB3-B707-4F2B-B3D7-C5C72A2C64EAQ39681051-9AB28D5B-F09B-4891-8039-6F350F6D364EQ40151992-0C75751F-1353-4C4F-977C-335F132A9F2AQ41378482-40FFC668-1CF0-445D-A561-6D07B4410B03Q42199306-0D73AD80-CCDE-4CCB-BCB6-D19845F97649Q43270685-25274DA7-957A-464C-BB2C-ED031D0A1C9DQ43289951-50FC70B6-0AB7-4C8E-ADC9-0705DCA42697Q43618813-4A33E4C7-6E8E-4A5D-9DB7-E91A729DD2F1Q44309891-57368E61-A996-4F21-BAC7-7FBF49DDA5B5Q44419599-E2E17977-7B39-497F-8DDC-C1C96AB3AB8DQ44570119-D6FD49F9-DC80-4D59-B5E2-81CF15D7ED3DQ44646733-D1755AE0-D200-4A02-AE06-7EC6336B000FQ44725924-169DE3A5-FCE8-4EA3-922C-8D9C4B6385C8Q44991120-423EE4AE-3E74-475B-93B3-3E00C6396A4EQ47947378-5F09DB06-01D0-4FF2-A26C-94F692A3D5ABQ48022374-D9404748-5799-440A-A3ED-D60970E806E9Q51044550-82143F60-FA3F-4B97-8EF7-30BEBECE4331Q52005594-127B5C8D-F230-409B-B093-96CEB237123DQ53005649-74CEDA72-C8BA-4598-9D4F-95E8FCCD52F0Q54509541-FC87E293-B7E0-4D3D-95E3-06DBFD796563Q54641569-6EAFB19C-9668-4B67-9F25-4E1D9520E837Q57425794-12C5BBA1-3C6C-4E9C-A35C-E648B0A75FDFQ57819980-3A57F16D-57E4-4FCD-9C85-49526DC3AC22Q57820342-3D21EE71-8D8A-405F-8E4C-BC676FC73FB2Q57820372-1BE4B94D-8F26-4DFD-BA12-EA8360CB8035Q57944398-5F3D7FBE-5ED6-4FA8-A436-CF4D7B5C8438Q73880861-93F1FE72-5795-488F-8B3B-AFD6634B47FBQ79184040-1D22C29A-C520-4874-B464-4811A44CB222Q79219162-50C7BECE-E2F3-41E9-9784-9155F60B86A3Q79269647-F9C7E37C-D374-4A5A-B3F0-EAEB33E251C3Q80152504-33FE5EDA-2493-4855-A111-EE568DAB0801Q82714074-43EC3487-A955-47BF-B63C-7DECC4B6FB4B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francesco Panzuto
@ast
Francesco Panzuto
@en
Francesco Panzuto
@es
Francesco Panzuto
@nl
Francesco Panzuto
@sl
type
label
Francesco Panzuto
@ast
Francesco Panzuto
@en
Francesco Panzuto
@es
Francesco Panzuto
@nl
Francesco Panzuto
@sl
prefLabel
Francesco Panzuto
@ast
Francesco Panzuto
@en
Francesco Panzuto
@es
Francesco Panzuto
@nl
Francesco Panzuto
@sl
P106
P1153
6602461515
P21
P31
P496
0000-0003-2789-4289